Q2 2025 Aurora Cannabis Inc Earnings Call Transcript
Key Points
- Aurora Cannabis Inc (ACB) reported a 29% increase in net revenue, with global medical cannabis revenue growing by 41% year-over-year.
- The company achieved record adjusted EBITDA, marking its eighth consecutive quarter of positive adjusted EBITDA.
- International medical cannabis revenue increased by 93%, with high-margin international revenue surpassing Canadian medical cannabis revenue for the first time.
- Aurora Cannabis Inc (ACB) maintained a strong balance sheet with approximately $152 million in cash and cash equivalents and no debt in its cannabis business.
- The company expanded its product offerings in Australia, contributing to increased sales and market presence.
- Consumer cannabis net revenue declined to $10.4 million from $12 million in the previous year, reflecting a strategic focus on higher-margin international business.
- Adjusted gross margin in consumer cannabis decreased to 14% from 27% due to a shift in product sales.
- The plant propagation segment experienced a decrease in adjusted gross margin to 19% from 22%, attributed to seasonal fluctuations and ramp-up costs.
- The company faces regulatory hurdles in international markets, which can impact the timing and consistency of shipments.
- Aurora Cannabis Inc (ACB) continues to operate in a challenging Canadian recreational cannabis market with lower margins and regulatory complexities.
Greetings, and welcome to the Aurora Cannabis Inc., second quarter 2025 results conference call. (Operator Instructions) This conference call is being recorded today, Wednesday, November 6, 2024.
I would now like to turn the conference over to your host, Kevin Niland, Director of Strategic Finance and Investor Relations. Please go ahead.
Hello, everyone, and thank you for joining us. On the line with me are Miguel Martin, Executive Chairman and CEO, Simona King, CFO. This morning, we filed our financials for the second quarter 2025, period ending September 30, 2024, issued a news release containing our quarterly results. Our financial statements, MD&A and this news release are available on our IR website and can also be accessed via SEDAR+ and EDGAR.
In today's conference call, this is a reminder that certain matters to constitute forward-looking statements and are subject to risks and uncertainties related to our future financial or business
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
